Picrorhiza kurroa Prevents Memory Deficits by Inhibiting NLRP3 Inflammasome Activation and BACE1 Expression in 5xFAD Mice

Journal: Neurotherapeutics Publication Year: 2020 Study Type: Preclinical — In vivo (5xFAD mouse) PMCID: PMC7007473 | Link: View on PubMed Central

Sep 19, 2026 | 1 min read

Research Gist

This study examined Picrorhiza kurroa in a transgenic mouse model that develops progressive neurodegenerative changes. The focus was on microglia, the brain's resident immune cells. Under sustained stress, microglia can shift into an inflammatory state that contributes to neuronal damage. Treatment with Kutki shifted these cells toward an anti-inflammatory phenotype instead. The NLRP3 inflammasome, a protein complex that drives inflammatory signalling, showed reduced activation. Memory performance was protected in treated animals. Neuroinflammation is a shared driver across several neurodegenerative conditions, including Parkinson's, though this particular model was designed for Alzheimer's research.

Key Learnings

  • Microglia shifted toward an anti-inflammatory phenotype in treated animals.
  • NLRP3 inflammasome activation, a driver of inflammatory signalling, was reduced.
  • Memory performance was protected compared with untreated animals.
  • Neuroinflammation is a shared driver across several neurodegenerative conditions.
  • This model was designed for Alzheimer's research, not Parkinson's specifically.